Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

381 evidence items · page 12 / 16

10 %Among 436 treatment-naïve Nigerian breast cancer patients, 10% were classified as having high tumor-infiltrating lymphocytes (TILs) (≥40%).

Nigeriacancer du seinpublished 2026Breast cancer research and treatmentPubMeddocument of 14 observations

27 participantsTwenty-seven out of 46 participants (58.6%) had a diagnostic interval within 60 days.

Nigeriacancer du seinpublished 2025BMC cancerPubMeddocument of 11 observations

3.9 %Nigerian breast cancer patients have a BRCA2 mutation frequency of 3.9%.

Nigeriacancer du seinpublished 2012International journal of cancereurope_pmcdocument of 2 observations

33 %Of those who did not receive surgery, the most common reason was cost (n = 41/125, 33%).

Nigeriacancer du seinpublished 2026Psycho-oncologyPubMeddocument of 11 observations

5,192.77 USDThe mean cost of care was $5192.77 (SD $4567.71).

Nigeriacancer du seinpublished 2024Journal of cancer policyPubMeddocument of 4 observations

100 %Among 130 breast cancer patients who underwent multiple treatment modalities, 100% risked financial catastrophe.

Nigeriacancer du seinpublished 2025American journal of surgeryPubMeddocument of 13 observations

90.3 %The majority, 316 (90.3%) of the 350 female undergraduates, had poor knowledge of breast cancer and screening.

Nigeriacancer du seinpublished 2022African health sciencesPubMeddocument of 5 observations

6.7 %Pathogenic BRCA1/2 variants were identified in 6.7% of breast cancer patients.

Nigeriacancer du seinpublished 2025Technology in cancer research & treatmentPubMeddocument of 2 observations

26.6 %25 out of 94 women with breast cancer perceived treatment of discomfort as the main benefit of exercise, representing 26.6%.

Nigeriacancer du seinpublished 2021Breast diseasePubMeddocument of 4 observations

40 %Among 607 patients diagnosed with breast cancer in Nigeria between January 2010 and December 2018, 40% were estrogen receptor positive.

Nigeriacancer du seinobserved 2010–2018published 2021International journal of cancerPubMeddocument of 12 observations

54.93 %54.93% of the respondents had good knowledge of breast self-examination.

Nigeriacancer du seinpublished 2023BMC women's healthPubMeddocument of 12 observations

72 %Seventy-two percent of households had to borrow money as a result of accessing breast cancer treatment.

Nigeriacancer du seinpublished 2022The Pan African medical journalPubMeddocument of 9 observations

44 %One hundred patients (44%) underwent mastectomy, 97 within 1 year of diagnosis.

Nigeriacancer du seinpublished 2026Psycho-oncologyPubMeddocument of 11 observations

10.1 %A hybrid breast cancer genetics education program for Nigerian health care providers resulted in a further 10.1% gain in knowledge after the in-person workshop.

Nigeriacancer du seinpublished 2026JCO global oncologyPubMeddocument of 5 observations

15.7 %The proportion of metastatic breast cancer cases was 15.7% during 2016–2018.

Nigeriacancer du seinobserved 2016-2018published 2023West African journal of medicinePubMeddocument of 8 observations

30.6 %30.6% of the respondents had average knowledge of the risk factors and symptoms of breast cancer.

Nigeriacancer du seinpublished 2024West African journal of medicinePubMeddocument of 7 observations

On multivariate analysis, D-dimer and fibrinogen were independently related to lymph node involvement in breast cancer patients.

Nigeriacancer du seinpublished 2021Cancer investigationPubMeddocument of 4 observations

55.6 %Among 6,274 participants, 55.6% (3,478) were breast cancer cases.

Nigeriacancer du seinpublished 2024Cancer causes & control : CCCPubMeddocument of 5 observations

20.09 %Middle-aged individuals had 20.09% knowledge about red meat/smoked foods as a breast cancer risk factor.

Nigeriacancer du seinpublished 2024JCO global oncologyPubMeddocument of 12 observations

45.97 %Among 3,263 breast histopathology records reviewed from 2015 to 2023, most breast cancer cases were in young adults (20–39 years) at 45.97%.

Nigeriacancer du seinobserved 2015 to 2023published 2025Scientific reportsPubMeddocument of 12 observations

5 %Among cases, 5.0% (50 individuals) were classified as high risk using a lifetime absolute risk threshold of 10% or higher in the PRS plus PV model.

Nigeriacancer du seinpublished 2025JAMA network openPubMeddocument of 6 observations

44.41 %The right breast had a malignancy rate of 44.41% among the 3,263 breast histopathology records.

Nigeriacancer du seinobserved 2015 to 2023published 2025Scientific reportsPubMeddocument of 12 observations

D-dimer and fibrinogen were significantly positively correlated with ECOG, disease stage, lymph node involvement, and tumor size in breast cancer patients.

Nigeriacancer du seinpublished 2021Cancer investigationPubMeddocument of 4 observations

46.5 %46.5% of breast cancer patients underwent surgery.

Nigeriacancer du seinobserved May 2009–January 2019published 2021CancerPubMeddocument of 7 observations

21 participantsTwenty-one out of 46 participants (46%) recognized family history as a risk factor for breast cancer.

Nigeriacancer du seinpublished 2025BMC cancerPubMeddocument of 11 observations

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.